Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT00488878
- Status
- Recruiting
Conditions
- Low Grade Ovarian Serous Adenocarcinoma
- Malignant Ovarian Neoplasm
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
- Primary Peritoneal Low Grade Serous Adenocarcinoma
- Psammocarcinoma
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biospecimen Collection — PROCEDUREPatients' residual tissue samples are collected
- Electronic Health Record Review — OTHERMedical records are reviewed
Study Details
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Key Dates
- Start date
- May 19, 2006
- Status verified
- Feb 2026
- Primary completion
- May 1, 2034
- Completion
- May 1, 2035
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Observational (electronic health record review)Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.
Primary Outcome Measure
Prospective and retrospective data collection on disease characterization, treatment, and outcomes [ Time Frame: Up to 28 years ]
Central Contacts
- Lisa Nathan713-745-3837
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | David M. Gershenson 713-563-4535 David M. Gershenson (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerRecruiting · NRG Oncology · Birmingham, Alabama
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- A Study of Intra-operative Imaging in Women With Ovarian CancerPHASE3 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey